Page last updated: 2024-08-21

levonorgestrel and thromboxane b2

levonorgestrel has been researched along with thromboxane b2 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, LL; Zhang, JY1
Belsey, EM; Croxtall, JD; d'Arcangues, C; Elder, MG; Patel, L; Sullivan, MH; White, JO1
Kuusi, T; Tikkanen, MJ; Viinikka, L; Ylikorkala, O1
Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF1

Trials

1 trial(s) available for levonorgestrel and thromboxane b2

ArticleYear
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
    Contraception, 1995, Volume: 51, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2

1995

Other Studies

3 other study(ies) available for levonorgestrel and thromboxane b2

ArticleYear
[Intrauterine device-induced menorrhagia and endometrial content of prostacyclins].
    Zhonghua fu chan ke za zhi, 1992, Volume: 27, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Endometrium; Epoprostenol; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Oligomenorrhea; Thromboxane B2

1992
Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring.
    Contraception, 1991, Volume: 43, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Biopsy; Chromatography, High Pressure Liquid; Contraceptive Agents; Contraceptive Devices, Female; Dinoprostone; Endometrium; Female; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotriene B4; Levonorgestrel; Norgestrel; Prostaglandins; Thromboxane B2

1991
Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 65, Issue:6

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cholesterol, HDL; Contraceptives, Oral; Desogestrel; Epoprostenol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes; Thromboxane A2; Thromboxane B2

1987